In this video, Dr. K K Aggarwal, President Heart Care Foundation of India and Group Editor in Chief MEDtalks, will talk about the duration of dual antiplatelet therapy given after LAD stenting. Most of such patients are put on the combination of clopidogrel and aspirin during stenting. The dual antiplatelet drug should be re-evaluated every six months. After six months, if the patient is at low risk of bleeding and has tolerated the medicine then should be continued for more 18 months. After this, only aspirin can be continued.
Recipient of Padma Shri, Vishwa Hindi Samman, National Science Communication Award and Dr B C Roy National Award, Dr Aggarwal is a physician, cardiologist, spiritual writer and motivational speaker. He is the Past President of the Indian Medical Association and President of Heart Care Foundation of India. He is also the Editor in Chief of the IJCP Group, Medtalks and eMediNexus